Document is current
Any future updates will be listed below
-
Authors
Ikushima, Akie
Ishimura, Takuya
Mori, Keita P.
Yamada, Hiroyuki
Sugioka, Sayaka
Ishii, Akira
Toda, Naohiro
Ohno, Shoko
Kato, Yukiko
Handa, Takaya
Yanagita, Motoko
Yokoi, Hideki
-
Funding
Funding for this research was provided by:
Japanese Society of Peritoneal Dialysis
Japan Society for the Promotion of Science (23K07717, 24K19129, 23K15227, 22K08310, 21K16189, 23K15226)
Japan Agency for Medical Research and Development (19gm1210009)
Smoking Research Foundation
Japanese Association of Dialysis Physicians
Kyoto Health Care Society
Tsuchiya Foundation
- License Information
-
More Information
Article History
Received: 8 May 2024
Accepted: 2 September 2024
First Online: 11 September 2024
Competing interests
: H. Yokoi has received Speakers Bureau from AstraZeneca. M. Yanagita has received research grants from Mitsubishi Tanabe Pharmaceutical Corporation and Boehringer Ingelheim. All remaining authors declared no competing interests.
: The human sample study was approved by the Ethics Committee for Human Research of the Graduate School of Medicine, Kyoto University (Approval No. R3781). All animal experiments were conducted in accordance with the Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions and were approved by the Animal Experimentation Committee of Kyoto University Graduate School of Medicine (Approval number; MedKyo23154). All methods were carried out in accordance with relevant guidelines and regulations including ARRIVE guidelines.
